Skip to main content
Equibles

GRFS · Grifols SA

Track GRFS — free

Use GRFS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GRFS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.31 +0.01 (+0.14%) At close · Oct 2
Rebalance outlook locked
Market Cap
$5.00B
Shares
680.58M
Volume · Oct 2 390.35K Avg daily vol (3M) 604.84K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$7.31 Open$7.30 Day$7.24–7.36 52W close$7.02–10.02 Avg vol 30d557K Short int3.4M · 0.5% float · 8.8d Short vol48% Last earningsJul 28, 2026 DataJan 2020–Oct 2026

Up next

Next earnings call
Oct 23, 2026 Est · unconfirmed · in 3 wks
Q1 2026 earnings call transcript
call held May 7, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+4.3%
Year over year
Operating margin
16.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-26.8%
Trailing year
Short interest
0.5%
Latest settlement · 8.8 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Moderate
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −10%
below
Price vs 50-day avg −5%
below
RSI (14) 41
neutral
MACD trend Positive
52-week position 10%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −7%
trailing
6-month return −13%
trailing
YTD return −22%
this year
Relative strength −25%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $8 › 200d $8 — 200d above 50d
Institutional flow Distributing
1 of 164 funds reported for Sep 30 · net -3.5K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.50% of float · ▼ -0.1% MoM · 8.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
164 holders — mid 3-yr range
Squeeze score 50
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Moderate
Volatility 32%
annualized · 1-yr
Max drawdown −30%
past year
ATR 2.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Mar 31, 2026
Adjusted EBITDA margin · full year 2026 Non-GAAP Initiated at least 25%
Adjusted EBITDA growth · full year 2026 Non-GAAP Initiated 5% – 9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−10% Bearish
Price vs 50-day avg
−5% Bearish
RSI (14)
41 Neutral
MACD trend
Positive Bullish
52-week position
10% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $8 › 200d $8 — 200d above 50d
Institutional flow Distributing
1 of 164 funds reported for Sep 30 · net -3.5K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.50% of float · ▼ -0.1% MoM · 8.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
164 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $7 Now $7 · 10% Range high $10
vs 200-day avg -10% vs 50-day avg -5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - General — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GRFS
Grifols SA
this stock
$5.00B -21.8% — — 0.5%
LLY
ELI LILLY & Co
 $1.11T +6.3% +44.7% 39.7 0.8%
JNJ
Johnson & Johnson
 $653.61B +23.7% +6.0% 31.5 0.9%
ABBV
AbbVie Inc.
 $466.80B +15.0% +8.6% 74.6 1.1%
MRK
Merck & Co., Inc.
 $367.07B +37.1% +1.3% 119.0 1.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
164
% held
21.0%
Reported
1 of 164
Top holder
BRANDES INVESTMENT PARTNE…
Held Float
View
Held by Funds
Fund positions
25
View
Short & Settlement
Short Interest Falling
Shares short
3.4M
Days to cover
8.8d
Change
-2.8K sh
View
Short Volume
Short vol %
48%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
290
Value
$2.3K
As of
Sep 8, 2026
View
Off-Exchange
Off-exchange %
52.8%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Daniel Goldman
Amount
$1.0K–$15.0K
Traded
Mar 31, 2023
View
Filings
SEC Filings
Latest
6-K
Filed
Jul 30, 2026
This year
12
View
Earnings & Events
Webcasts
Last webcast
Jul 28, 2026
View

Performance

5D 20D 120D MTD YTD
GRFS -0.5% -7.2% -12.6% +0.0% -21.8%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -0.3% -6.8% -24.7% -0.9% -34.7%
Key facts CIK 1438569 CUSIP 398438408 13F (30d) 4 filings 4 filers Visit website Investor relations